New UVA research reveals a robust role for a particular molecule in Alzheimer's and potentially many other neurodegenerative diseases.
An inexpensive HIV drug outperforms monthly eye injections for people with diabetic macular edema, an initial study suggests.
Natasha D. Sheybani, PhD, will use the funds to support her efforts to enhance the safety, effectiveness and precision of immunotherapy drugs by combining them with focused ultrasound.
The School of Medicine alum brings a deep scientific background and a track record of success at taking discoveries from the bench to the bedside.
Children in Texas have been diagnosed with vitamin A poisoning, and our Dr. Christopher Holstege hopes to keep it from happening again.
A major trial has identified a drug to help stop the spread of COVID-19, which could be particularly important for people at high risk.